Literature DB >> 19995443

Three synchronous primary carcinomas in a patient with HNPCC associated with a novel germline mutation in MLH1: Case report.

Cristian D Valenzuela1, Harvey G Moore, William C Huang, Elsa W Reich, Herman Yee, Harry Ostrer, H Leon Pachter.   

Abstract

BACKGROUND: MLH1 is one of six known genes responsible for DNA mismatch repair (MMR), whose inactivation leads to HNPCC. It is important to develop genotype-phenotype correlations for HNPCC, as is being done for other hereditary cancer syndromes, in order to guide surveillance and treatment strategies in the future. CASE
PRESENTATION: We report a 47 year-old male with hereditary nonpolyposis colorectal cancer (HNPCC) associated with a novel germline mutation in MLH1. This patient expressed a rare and severe phenotype characterized by three synchronous primary carcinomas: ascending and splenic flexure colon adenocarcinomas, and ureteral carcinoma. Ureteral neoplasms in HNPCC are most often associated with mutations in MSH2 and rarely with mutations in MLH1. The reported mutation is a two base pair insertion into exon 10 (c.866_867insCA), which results in a premature stop codon.
CONCLUSION: Our case demonstrates that HNPCC patients with MLH1 mutations are also at risk for ureteral neoplasms, and therefore urological surveillance is essential. This case adds to the growing list of disease-causing MMR mutations, and contributes to the development of genotype-phenotype correlations essential for assessing individual cancer risk and tailoring of optimal surveillance strategies. Additionally, our case draws attention to limitations of the Amsterdam Criteria and the need to maintain a high index of suspicion when newly diagnosed colorectal cancer meets the Bethesda Criteria. Establishment of the diagnosis is the crucial first step in initiating appropriate surveillance for colorectal cancer and other HNPCC-associated tumors in at-risk individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995443      PMCID: PMC2795749          DOI: 10.1186/1477-7819-7-94

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


  23 in total

Review 1.  Hereditary colorectal cancer.

Authors:  Henry T Lynch; Albert de la Chapelle
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

2.  Frequent microsatellite instability in sporadic tumors of the upper urinary tract.

Authors:  Arndt Hartmann; Livia Zanardo; Tina Bocker-Edmonston; Hagen Blaszyk; Wolfgang Dietmaier; Robert Stoehr; John C Cheville; Kerstin Junker; Wolf Wieland; Ruth Knuechel; Josef Rueschoff; Ferdinand Hofstaedter; Richard Fishel
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Patient accuracy of reporting on hereditary non-polyposis colorectal cancer-related malignancy in family members.

Authors:  N Katballe; S Juul; M Christensen; T F Ørntoft; F P Wikman; S Laurberg
Journal:  Br J Surg       Date:  2001-09       Impact factor: 6.939

4.  MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.

Authors:  H F Vasen; A Stormorken; F H Menko; F M Nagengast; J H Kleibeuker; G Griffioen; B G Taal; P Moller; J T Wijnen
Journal:  J Clin Oncol       Date:  2001-10-15       Impact factor: 44.544

5.  Screening for urinary tract cancer with urine cytology in Lynch syndrome and familial colorectal cancer.

Authors:  T Myrhøj; M-B Andersen; I Bernstein
Journal:  Fam Cancer       Date:  2008-04-04       Impact factor: 2.375

Review 6.  Diagnosis of urothelial carcinoma from urine.

Authors:  Bernard Têtu
Journal:  Mod Pathol       Date:  2009-06       Impact factor: 7.842

7.  Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening.

Authors:  Catherine Julié; Christophe Trésallet; Antoine Brouquet; Céline Vallot; Ute Zimmermann; Emmanuel Mitry; François Radvanyi; Etienne Rouleau; Rosette Lidereau; Florence Coulet; Sylviane Olschwang; Thierry Frébourg; Philippe Rougier; Bernard Nordlinger; Pierre Laurent-Puig; Christophe Penna; Catherine Boileau; Brigitte Franc; Christine Muti; Hélène Hofmann-Radvanyi
Journal:  Am J Gastroenterol       Date:  2008-08-27       Impact factor: 10.864

8.  Differential cancer predisposition in Lynch syndrome: insights from molecular analysis of brain and urinary tract tumors.

Authors:  A H S Gylling; T T Nieminen; W M Abdel-Rahman; K Nuorva; M Juhola; E I Joensuu; H J Järvinen; J-P Mecklin; M Aarnio; P T Peltomäki
Journal:  Carcinogenesis       Date:  2008-06-12       Impact factor: 4.944

9.  Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.

Authors:  E Barrow; W Alduaij; L Robinson; A Shenton; T Clancy; F Lalloo; J Hill; D G Evans
Journal:  Clin Genet       Date:  2008-06-28       Impact factor: 4.438

10.  Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

Authors:  Johanne Geary; Peter Sasieni; Richard Houlston; Louise Izatt; Ros Eeles; Stewart J Payne; Samantha Fisher; Shirley V Hodgson
Journal:  Fam Cancer       Date:  2007-10-16       Impact factor: 2.375

View more
  3 in total

1.  Molecular signaling mechanisms of apoptosis in hereditary non-polyposis colorectal cancer.

Authors:  Samar Hassen; Nawab Ali; Parimal Chowdhury
Journal:  World J Gastrointest Pathophysiol       Date:  2012-06-15

2.  Extracolonic manifestations of lynch syndrome.

Authors:  Brian J Bansidhar
Journal:  Clin Colon Rectal Surg       Date:  2012-06

3.  Report of a Novel Mutation in MLH1 Gene in a Hispanic Family from Puerto Rico Fulfilling Classic Amsterdam Criteria for Lynch Syndrome.

Authors:  Juan M Marqués-Lespier; Yaritza Diaz-Algorri; Maria Gonzalez-Pons; Marcia Cruz-Correa
Journal:  Gastroenterol Res Pract       Date:  2014-10-20       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.